Press Releases Latest Jul 10, 2024 Theratechnologies Reports Financial Results and Announces Positive Net Income for Second Quarter 2024 Press Releases Year None202420232022202120202019201820172016201520142013 Jul 10, 2024 Theratechnologies Reports Financial Results and Announces Positive Net Income for Second Quarter 2024 Jun 26, 2024 Theratechnologies to Announce Second Quarter 2024 Financial Results and Provide Business Update May 23, 2024 Theratechnologies’ Sudocetaxel Zendusortide ASCO 2024 Presentation Demonstrates Signs of Long-Term Efficacy and Manageable Safety Profile in Patients with Solid Tumors May 09, 2024 Theratechnologies Reports on its Annual Meeting of Shareholders May 02, 2024 Theratechnologies to Present Long-Term Efficacy, Safety and Pharmacokinetic Data on Use of TH1902 (sudocetaxel zendusortide) in Solid Tumors at 2024 ASCO Meeting Apr 15, 2024 Theratechnologies Announces Mailing of Management Proxy Circular in Connection with its Annual Meeting of Shareholders Apr 11, 2024 Theratechnologies to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference Apr 10, 2024 Theratechnologies Reports Financial Results and Provides Business Update for First Quarter 2024 Apr 08, 2024 Theratechnologies Preclinical Data Presentation at AACR 2024 Highlights Versatility and Flexibility of SORT1+ Technology™ Oncology Platform Apr 05, 2024 Theratechnologies Appoints Elina Tea to its Board of Directors Current page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Next page › Last page » Displaying 1 - 10 of 365
Jul 10, 2024 Theratechnologies Reports Financial Results and Announces Positive Net Income for Second Quarter 2024
Jul 10, 2024 Theratechnologies Reports Financial Results and Announces Positive Net Income for Second Quarter 2024
Jun 26, 2024 Theratechnologies to Announce Second Quarter 2024 Financial Results and Provide Business Update
May 23, 2024 Theratechnologies’ Sudocetaxel Zendusortide ASCO 2024 Presentation Demonstrates Signs of Long-Term Efficacy and Manageable Safety Profile in Patients with Solid Tumors
May 02, 2024 Theratechnologies to Present Long-Term Efficacy, Safety and Pharmacokinetic Data on Use of TH1902 (sudocetaxel zendusortide) in Solid Tumors at 2024 ASCO Meeting
Apr 15, 2024 Theratechnologies Announces Mailing of Management Proxy Circular in Connection with its Annual Meeting of Shareholders
Apr 11, 2024 Theratechnologies to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference
Apr 10, 2024 Theratechnologies Reports Financial Results and Provides Business Update for First Quarter 2024
Apr 08, 2024 Theratechnologies Preclinical Data Presentation at AACR 2024 Highlights Versatility and Flexibility of SORT1+ Technology™ Oncology Platform